Sun Pharma preps for $12-billion Organon bid in biggest overseas pharma M&A by Indian co
Sun Pharma is moving forward with a $12 billion offer for Organon & Co. This acquisition would be the largest for an Indian pharma company. Sun Pharma is finalizing financing for the deal. Organon specializes in women’s health. The company is also facing competition from other global consortiums. This move signifies Sun Pharma’s ambition to […]
Financial services bear maximum brunt of late-March FPI sell-offs
Financial services bore the brunt of foreign investor selling in the latter half of March, with outflows exceeding ₹60,000 crore, the highest since 2012. This broad-based selling, driven by valuation concerns and geopolitical uncertainty, saw significant withdrawals from banking, automobiles, and construction sectors.
After five-day surge, D-Street slips through ceasefire cracks
Indian equity markets experienced a downturn on Thursday, with the Nifty 50 and Sensex falling approximately 1% each. This decline followed renewed geopolitical uncertainty in West Asia, which soured investor sentiment and led to profit booking after a recent rally. Crude oil prices also spiked amid the developing situation.
Macro buffers to help India tide over Gulf crisis: World Bank
India’s economic growth for FY27 is projected at 6.6 percent. The World Bank notes potential risks from the Gulf conflict impacting global energy prices. However, India’s economy is strong, supported by reserves and low inflation. Growth is expected to average 7.1 percent from FY28 to FY29. Boosting private sector growth is key for job creation […]
F&O watch: BSE gets Sebi nod to launch BSE Focused IT Index derivatives
Securities and Exchange Board of India approved BSE to launch derivatives on its Focused IT Index, tracking 14 major IT firms. The move comes as the index records sharp declines, offering new hedging and trading opportunities for investors.
$67 billion! Dalal Street braces for 81 IPO lock-in expiries in next 3 months. Check details
A wave of IPO lock-in expiries is set to hit Dalal Street, with 81 companies unlocking nearly $70 billion worth of shares over the next three months, though large-scale selling may be limited as promoters are likely to retain holdings.
Why FPI interest in India ‘has pretty much died out’: Nithin Kamath points to valuations, taxes and global alternatives
Foreign investor interest in Indian equities is weakening due to geopolitical risks, high valuations, weak AI opportunities, and tax concerns. Capital is shifting to other markets, while volatile FPI flows and recent sell-offs continue to pressure benchmark indices and investor sentiment.
Housing finance stocks near inflection point, Bernstein picks 2 favourites
Affordable housing finance stocks are nearing a turning point. Bernstein highlights attractive valuations and improving growth and asset quality. HomeFirst and Aadhar Housing Finance are named as preferred investments. The sector is poised for a turnaround, offering significant upside potential for investors. This presents a favorable entry point for the segment.
Rupee at risk? BOP pressure, oil shock and capital flows hold the key, says Rahul Bajoria
The Indian rupee faces potential weakening to 94 against the US dollar by mid-2026 due to rising oil prices and a widening current account deficit. While the RBI is focused on preventing disorderly moves rather than defending specific levels, attracting capital inflows remains crucial for currency stabilization amidst global uncertainties.
Nimesh Chandan backs private banks, cyclicals as valuations turn attractive
Indian markets are experiencing a temporary disruption, not a fundamental shift. Bajaj Finserv AMC’s Nimesh Chandan sees this as a chance to buy good companies at attractive prices. Financials, materials, and industrials are favored sectors. Consumption is recovering broadly. Long-term investors can build positions for future growth.